Skip to main content
. 2008 Mar;151(3):407–413. doi: 10.1111/j.1365-2249.2007.03577.x

Table 1.

Immunosuppressive treatment of seven graft-versus-host disease (GVHD) patients undergoing extracorporeal photochemotherapy and enrolled in the study.

Patients Sex GVHD Treatment Number of ECP cycles performed when enrolled
1 F Chronic Tacrolymus, mophetil mycophenolate 3rd cycle
2 F Acute Prednisone, cyclosporine 2nd cycle
3 M Acute Cyclosporine 3rd cycle
4 F Chronic Prednisone 2nd cycle
5 M Acute Prednisone 2nd cycle
6 M Chronic Cyclosporine, prednisone 7th cycle
7 M Acute Cyclosporine, prednisone 2nd cycle

ECP: extracorporeal photochemotherapy.